Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Antigen-presenting cell (APC) receptors for HSP70 are a group of cell surface proteins that mediate the uptake and immunological recognition of extracellular heat shock protein 70 (HSP70) (Source: NIH). Key members of this group include scavenger receptors such as CD91 (LRP1), LOX-1 (OLR1), and SREC-I (SCARF1), as well as signaling receptors like CD40 and Toll-like receptors (TLR2 and TLR4) (Source: PubMed). These receptors are essential for the chaperokine function of HSP70, where it acts as both a carrier for tumor-derived peptides and an adjuvant that stimulates the innate immune system (Source: ResearchGate). Upon binding to these receptors, HSP70-peptide complexes are internalized via endocytosis and directed into the cross-presentation pathway, allowing the associated antigens to be presented on MHC class I molecules to CD8+ T cells (Source: NIH). Simultaneously, the interaction triggers pro-inflammatory signaling cascades, primarily through the NF-κB pathway, which promotes the maturation of dendritic cells and the secretion of immunostimulatory cytokines (Source: Frontiers in Immunology). In the context of oncology, these receptors are the primary targets for HSP70-based cancer vaccines, which utilize the chaperone's ability to deliver tumor-specific antigens directly to APCs to elicit a potent anti-tumor immune response (Source: ClinicalTrials.gov). Therapeutic strategies involving these receptors include autologous tumor-derived HSP70 preparations and recombinant HSP70-antigen fusion proteins, which have been evaluated in clinical trials for various malignancies (Source: NIH). Beyond cancer, these receptors are involved in the pathogenesis of inflammatory and autoimmune conditions, such as vitiligo, where extracellular HSP70 acts as a danger signal to activate local immune cells (Source: MDPI).
Binding of HSP70-peptide complexes to these receptors facilitates endocytosis and cross-presentation of antigens on MHC class I molecules, while also triggering innate immune signaling and dendritic cell maturation.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Antigen-presenting cell receptors for HSP70.